Advertisement
U.S. markets closed

Cyteir Therapeutics, Inc. (CYT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
3.0700-0.0300 (-0.97%)
At close: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close3.1000
Open3.0800
Bid3.0700 x 1000
Ask3.0800 x 900
Day's Range3.0600 - 3.0850
52 Week Range1.4300 - 3.1900
Volume162,569
Avg. Volume72,380
Market Cap110.514M
Beta (5Y Monthly)0.10
PE Ratio (TTM)N/A
EPS (TTM)-0.9300
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CYT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Cyteir Therapeutics, Inc.
    Daily – Vickers Top Buyers & Sellers for 07/05/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    8 months agoArgus Research
View more